1. Home
  2. NNY vs ANTX Comparison

NNY vs ANTX Comparison

Compare NNY & ANTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nuveen New York Municipal Value Fund

NNY

Nuveen New York Municipal Value Fund

SELL

Current Price

$7.62

Market Cap

154.3M

Sector

Finance

ML Signal

SELL

Logo AN2 Therapeutics Inc.

ANTX

AN2 Therapeutics Inc.

SELL

Current Price

$5.10

Market Cap

172.9M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
NNY
ANTX
Founded
1987
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
154.3M
172.9M
IPO Year
N/A
2022

Fundamental Metrics

Financial Performance
Metric
NNY
ANTX
Price
$7.62
$5.10
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
★ $9.00
AVG Volume (30 Days)
94.4K
★ 297.8K
Earning Date
01-01-0001
11-09-2026
Dividend Yield
★ 4.04%
N/A
EPS Growth
N/A
★ 32.56
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.55
$1.00
52 Week High
$8.94
$7.19

Technical Indicators

Market Signals
Indicator
NNY
ANTX
Relative Strength Index (RSI) 37.23 62.65
Support Level $7.55 $4.61
Resistance Level $8.14 $5.17
Average True Range (ATR) 0.12 0.46
MACD -0.03 0.13
Stochastic Oscillator 5.25 77.84

Price Performance

Historical Comparison
NNY
ANTX

About NNY Nuveen New York Municipal Value Fund

Nuveen New York Municipal Value Fund Inc. is a diversified closed-end management investment company. The Fund seeks to provide current income exempt from regular federal, New York State, and New York City income taxes, and from the federal alternative minimum tax for individuals, while enhancing portfolio value relative to the municipal bond market by investing in tax-exempt municipal bonds considered underrated, undervalued, or from undervalued municipal market sectors. It may invest in municipal securities such as lease obligations and certificates of participation, which provide an undivided interest in pools of municipal leases or installment purchase agreements.

About ANTX AN2 Therapeutics Inc.

AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology. Product candidate AN2-502998 Epetraborole.

Share on Social Networks: